Ipamorelin, also known as NNC 26-0161, functions as a selective growth hormone-releasing hormone (GHRH) agonist. This synthetic peptide mimics the effects of naturally occurring GHRH, stimulating the pituitary gland to release growth hormone (GH). Ipamorelin exhibits a high affinity for the GHRH receptor and features minimal side effects compared t